Rare diseases
Investigational molecules
Locations
Back to Norway2 clinical trials in Namsos, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)NorwayNorwayThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Multiple Sclerosis treatments are exploring the comparative effectiveness of different therapeutic approaches. Current research aims to evaluate treatment options for patients with relapsing-remitting MS, specifically investigating advanced biological therapies.
These investigations are designed to enhance our understanding of treatment efficacy in active MS, potentially leading to more personalized therapeutic strategies for patients aged 18-60 years.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
